Published in ISRN Oncol on April 27, 2011
EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII). Am J Cancer Res (2015) 1.29
Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology - Mainland China Subset Analysis of the PIONEER study. PLoS One (2015) 1.01
Brain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survival. Radiol Oncol (2014) 0.84
Differences in clinical presentation of non-small cell lung cancer in never-smokers versus smokers. J Thorac Dis (2013) 0.80
A rare case of lung cancer presenting as an ischioanal fossa mass. Indian J Med Paediatr Oncol (2017) 0.75
Association between thyroid cancer and epidermal growth factor receptor mutation in female with nonsmall cell lung cancer. Ann Thorac Med (2017) 0.75
Sex-specific incidence of EGFR mutation and its association with age and obesity in lung adenocarcinomas: a retrospective analysis. J Cancer Res Clin Oncol (2017) 0.75
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst (2000) 133.74
The biology of VEGF and its receptors. Nat Med (2003) 32.13
Cancer statistics, 2006. CA Cancer J Clin (2006) 30.71
Genes that mediate breast cancer metastasis to lung. Nature (2005) 19.85
Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med (2009) 13.47
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst (2005) 13.00
Global cancer statistics in the year 2000. Lancet Oncol (2001) 11.11
Genes that mediate breast cancer metastasis to the brain. Nature (2009) 8.23
The new lung cancer staging system. Chest (2009) 6.30
Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer. J Clin Oncol (2007) 5.55
Lung cancer. Lancet (2000) 3.93
Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology (2005) 2.19
Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer (1999) 2.17
Frequent EGFR mutations in brain metastases of lung adenocarcinoma. Int J Cancer (2006) 2.11
Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell (1993) 1.97
CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol (1990) 1.66
EGFR mutation is specific for terminal respiratory unit type adenocarcinoma. Am J Surg Pathol (2005) 1.42
High sensitivity detection of epidermal growth factor receptor mutations in the pleural effusion of non-small cell lung cancer patients. Cancer Sci (2006) 1.38
Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma. Eur Respir J (2008) 1.29
Five-year lung cancer survival: which advanced stage nonsmall cell lung cancer patients attain long-term survival? Cancer (2010) 1.25
Mutational analysis in cytological specimens of advanced lung adenocarcinoma: a sensitive method for molecular diagnosis. J Thorac Oncol (2007) 1.22
Malignant pleural disease. Eur J Radiol (2000) 1.18
Mutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathway. Br J Cancer (2001) 1.17
The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer. Br J Cancer (2001) 1.16
Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer. Int J Cancer (2006) 1.15
EGFR mutations and the terminal respiratory unit. Cancer Metastasis Rev (2010) 1.13
Epidermal growth factor receptor gene mutation and computed tomographic findings in peripheral pulmonary adenocarcinoma. J Thorac Oncol (2006) 1.09
Are there imaging characteristics associated with epidermal growth factor receptor and KRAS mutations in patients with adenocarcinoma of the lung with bronchioloalveolar features? J Thorac Oncol (2010) 1.08
Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs). Lung Cancer (2004) 1.00
EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil. Eur J Cancer (2007) 0.97
18F-fluoro-2-deoxy-glucose uptake predicts clinical outcome in patients with gefitinib-treated non-small cell lung cancer. Clin Cancer Res (2008) 0.95
Evaluation of CT findings for diagnosis of pleural effusions. Eur Radiol (2000) 0.87
Subtle pleural metastasis without large effusion in lung cancer patients: preoperative detection on CT. Korean J Radiol (2005) 0.81
A diagnostic model to detect silent brain metastases in patients with non-small cell lung cancer. Eur J Cancer (2008) 0.80
Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line. Lung Cancer (2008) 2.10
Incidental pulmonary emboli in oncology patients: prevalence, CT evaluation, and natural history. Radiology (2006) 1.93
Why don't physicians use their personal digital assistants? AMIA Annu Symp Proc (2003) 1.69
Fatal tumor lysis syndrome during radiotherapy for non-small-cell lung cancer. J Clin Oncol (2008) 1.62
Esophageal and laryngeal cancer incidentally found on [18F]fluorodeoxyglucose positron emission tomography/computed tomography during the staging workup for lung cancer. Clin Lung Cancer (2008) 1.46
Health behaviors of people with retinitis pigmentosa in the republic of Korea. Ophthalmic Epidemiol (2014) 1.41
Genome-wide analysis of DNA methylation and the gene expression change in lung cancer. J Thorac Oncol (2012) 1.16
Mammographic and sonographic findings of primary breast lymphoma. Clin Imaging (2007) 1.14
Activation of the mTOR signaling pathway in breast cancer and its correlation with the clinicopathologic variables. Breast Cancer Res Treat (2007) 1.10
Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome. Radiology (2005) 1.10
The role of MET activation in determining the sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors. Mol Cancer Res (2009) 1.07
Bronchoscopic features and bronchoscopic intervention for endobronchial hamartoma. Respirology (2009) 1.04
Association between age at diagnosis and the presence of EGFR mutations in female patients with resected non-small cell lung cancer. J Thorac Oncol (2010) 1.02
EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil. Eur J Cancer (2007) 0.97
18F-FDG uptake and EGFR mutations in patients with non-small cell lung cancer: a single-institution retrospective analysis. Lung Cancer (2010) 0.97
Therapeutic embolization of systemic arterial supply to normal basal segments of the left lower lobe of the lung. Respirology (2009) 0.95
18F-fluoro-2-deoxy-glucose uptake predicts clinical outcome in patients with gefitinib-treated non-small cell lung cancer. Clin Cancer Res (2008) 0.95
Relative tumor burden predicts metastasis-free survival in pediatric osteosarcoma. Pediatr Blood Cancer (2008) 0.92
Fine needle aspiration cytology of parathyroid lesions. Korean J Pathol (2013) 0.91
Synchronous multiple primary lung cancers with different response to gefitinib. Lung Cancer (2006) 0.91
Hepatic metabolism and biliary excretion of silymarin flavonolignans in isolated perfused rat livers: role of multidrug resistance-associated protein 2 (Abcc2). Drug Metab Dispos (2008) 0.90
A novel E1A-like inhibitor of differentiation (EID) family member, EID-2, suppresses transforming growth factor (TGF)-beta signaling by blocking TGF-beta-induced formation of Smad3-Smad4 complexes. J Biol Chem (2003) 0.89
Sorafenib hepatobiliary disposition: mechanisms of hepatic uptake and disposition of generated metabolites. Drug Metab Dispos (2013) 0.89
Phosphorylated S6K1 is a possible marker for endocrine therapy resistance in hormone receptor-positive breast cancer. Breast Cancer Res Treat (2010) 0.89
Squamous cell carcinoma arising from pulmonary hamartoma. Clin Nucl Med (2011) 0.88
Fine-needle aspiration cytology of pleomorphic carcinomas of the lung. Korean J Pathol (2012) 0.87
The survival outcomes of patients with resected non-small cell lung cancer differ according to EGFR mutations and the P21 expression. Lung Cancer (2007) 0.86
Transplanted xenogenic bone marrow stem cells survive and generate new bone formation in the posterolateral lumbar spine of non-immunosuppressed rabbits. Eur Spine J (2008) 0.86
Inhibition of S6K1 enhances glucose deprivation-induced cell death via downregulation of anti-apoptotic proteins in MCF-7 breast cancer cells. Biochem Biophys Res Commun (2013) 0.85
Fine needle aspiration cytology (FNAC) of gastrointestinal stromal tumor: an emphasis on diagnostic role of FNAC, cell block, and immunohistochemistry. J Korean Med Sci (2002) 0.84
Expression patterns of aurora kinase B, heat shock protein 47, and periostin in esophageal squamous cell carcinoma. Oncol Res (2009) 0.84
S6K1 inhibition enhances tamoxifen-induced cell death in MCF-7 cells through translational inhibition of Mcl-1 and survivin. Cell Biol Toxicol (2013) 0.84
Clinical utility of the Xpert MRSA assay for early detection of methicillin-resistant Staphylococcus aureus. Mol Med Rep (2012) 0.84
Adenomyomatous hamartoma of lung mimicking benign mucinous tumor in fine needle aspiration biopsy: a case report. Acta Cytol (2008) 0.83
Sustained overexpression of Redd1 leads to Akt activation involved in cell survival. Cancer Lett (2013) 0.83
Two pediatric osteosarcoma cases with delayed methotrexate excretion: its clinical course and management. Cancer Res Treat (2011) 0.83
Phosphorylated S6 kinase-1: a breast cancer marker predicting resistance to neoadjuvant chemotherapy. Anticancer Res (2013) 0.83
Clinical features reflect exon sites of EGFR mutations in patients with resected non-small-cell lung cancer. J Korean Med Sci (2007) 0.83
Gefitinib circumvents hypoxia-induced drug resistance by the modulation of HIF-1alpha. Oncol Rep (2009) 0.83
Significance of cytologic smears in the diagnosis of small cell carcinoma of the uterine cervix. Acta Cytol (2002) 0.82
Piperlongumine induces cell death through ROS-mediated CHOP activation and potentiates TRAIL-induced cell death in breast cancer cells. J Cancer Res Clin Oncol (2014) 0.82
Lung cancer presenting as an asymptomatic pneumatocele. Intern Med (2008) 0.82
Decreased hepatic breast cancer resistance protein expression and function in multidrug resistance-associated protein 2-deficient (TR⁻) rats. Drug Metab Dispos (2010) 0.82
Detection and identification of human papillomavirus using a PCR-restriction fragment mass polymorphism assay. Mol Med Rep (2011) 0.81
Role of adjuvant chemotherapy in malignant mucosal melanoma of the head and neck. Oral Oncol (2010) 0.81
Epidermal growth factor receptor mutations in female patients with postoperative recurrent non-small-cell lung cancer. J Cancer Res Ther (2012) 0.80
[Incidence and histologic patterns of bone marrow involvement of malignant lymphoma based on the World Health Organization classification: a single institution study]. Korean J Lab Med (2007) 0.80
Combination effect of cetuximab with radiation in colorectal cancer cells. Tumori (2011) 0.80
Sonographic changes after removing all benign breast masses with sonographically guided vacuum-assisted biopsy. Acta Radiol (2009) 0.80
A diagnostic model to detect silent brain metastases in patients with non-small cell lung cancer. Eur J Cancer (2008) 0.80
Combination therapy of cilengitide with belotecan against experimental glioblastoma. Int J Cancer (2013) 0.79
Inhibition of S6K1 enhances dichloroacetate-induced cell death. J Cancer Res Clin Oncol (2014) 0.79
Taurine supplementation restored the changes in pancreatic islet mitochondria in the fetal protein-malnourished rat. Br J Nutr (2011) 0.78
Prognostic value of E-cadherin expression in non-small cell lung cancer treated with gefitinib. Oncol Res (2010) 0.78
Classification of thymoma by fine needle aspiration biopsy according to WHO classification: a cytological algorithm for stepwise analysis in the classification of thymoma. Acta Cytol (2012) 0.78
Simple and versatile molecular method of copy-number measurement using cloned competitors. PLoS One (2013) 0.77
[Availability of fine needle aspirates for the assessment of HER2 gene amplification in invasive breast cancer patients]. Korean J Lab Med (2008) 0.77
Inhibition of vacuolar H+ ATPase enhances sensitivity to tamoxifen via up-regulation of CHOP in breast cancer cells. Biochem Biophys Res Commun (2013) 0.77
Epidermal growth factor receptor mutations and brain metastasis in patients with nonadenocarcinoma of the lung. J Cancer Res Ther (2016) 0.77
Myasthenia gravis in ectopic thymoma presenting as pleural masses. Lung Cancer (2007) 0.76
Cancers of the upper aerodigestive tract in Korea. J Korean Med Sci (2002) 0.75
Normal variations and anatomic pitfalls that may mimic diseases on coronary CT angiography. Int J Cardiovasc Imaging (2010) 0.75
Clinical outcome of low-grade central osteosarcoma and role of CDK4 and MDM2 immunohistochemistry as a diagnostic adjunct. J Orthop Sci (2015) 0.75
Primary Monophasic Synovial Sarcoma Arising in the Mesentery: Case Report of an Extremely Rare Mesenteric Sarcoma Confirmed by Molecular Detection of a SYT-SSX2 Fusion Transcript. Korean J Pathol (2012) 0.75
Mental health of people with retinitis pigmentosa. Optom Vis Sci (2013) 0.75
Sclerodermoid type of skin metastasis from lung cancer. Intern Med (2010) 0.75
High prevalence of c-RET expression in papillary thyroid carcinomas from the Korean population. Thyroid (2005) 0.75
Age at diagnosis predicts outcomes in gefitinib-treated female patients with non-small-cell lung cancer. Lung Cancer (2009) 0.75
ST segment elevation and T wave inversion on electrocardiograms 2 years after surgery for lung cancer. J Thorac Oncol (2008) 0.75
CT findings in non-small-cell lung cancer patients treated with gefitinib or erlotinib. J Cancer Res Ther (2012) 0.75
Serum human epidermal growth factor receptor 2 levels as a real-time marker for tumor burden in breast cancer patients. J Surg Oncol (2014) 0.75
[A case of del(16)(q22) in a patient with acute myeloid leukemia with complex karyotype]. Korean J Lab Med (2010) 0.75
[Late-onset neutropenia following rituximab therapy as a treatment of diffuse large B-cell lymphoma: a single institution study]. Korean J Lab Med (2010) 0.75
A case of pulmonary malignant epithelioid hemangioendothelioma misdiagnosed as adenocarcinoma by fine needle aspiration cytology. Diagn Cytopathol (2010) 0.75
Clinical significance of (18)F-FDG uptake by N2 lymph nodes in patients with resected stage IIIA N2 non-small-cell lung cancer: a retrospective study. Lung Cancer (2007) 0.75
[Four cases of hematologic malignancy following radioactive iodine therapy for thyroid cancer]. Korean J Lab Med (2008) 0.75
[Development of indicators to assess the stability of remnant blood samples stored in a biobank: experience at one institution]. Korean J Lab Med (2010) 0.75
[Correlation of chromosomal aberrations with prognostic markers in multiple myeloma patients--a single institution study]. Korean J Lab Med (2008) 0.75
[Near-tetraploidy acute myeloid leukemia with RUNX1-RUNX1T1 rearrangement due to cryptic t(8;21)]. Korean J Lab Med (2009) 0.75
Presence of malignant mesothelial cells in the sputum. Intern Med (2008) 0.75
[HDL cholesterol reduction during rosiglitazone and fenofibrate treatment in a type 2 diabetes mellitus patient with dyslipidemia]. Korean J Lab Med (2010) 0.75
Synchronous small and non-small cell lung cancer in a patient with previous tuberculosis. Intern Med (2007) 0.75
Gallbladder cancer presenting as an isolated large lung mass. Clin Nucl Med (2009) 0.75
Isolating bronchial epithelial cell preparations from gross lung specimens. In Vitro Cell Dev Biol Anim (2009) 0.75
Neoplastic fever caused by lung cancer. J Thorac Oncol (2007) 0.75
Noncalcified ductal carcinoma in situ: imaging and histologic findings in 36 tumors. J Ultrasound Med (2009) 0.75